Patents Assigned to Foundation
  • Patent number: 11154404
    Abstract: A spinal fixation system includes an expandable disc replacement body and an adjustment mechanism. The expandable disc replacement body includes a first wall, a second wall, a hinge connecting the first wall and the second wall, and a first bone-screw receiving section at a proximal end of the first wall. The adjustment mechanism is positioned between the first wall and the second wall, and an angle between the first wall and the second wall can be varied by movement of the adjustment mechanism.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: October 26, 2021
    Assignee: Mayo Foundation for Medical Education and Research
    Inventors: Brett Freedman, April V. Krivoniak, Kendall D. Dennis
  • Patent number: 11155870
    Abstract: Method for determining developmental fate of early embryos comprises measuring the expression level of a gene selected from the group consisting of CDKN1C, IGF2R, MAGEL2, MKRN3, NAP1L5, NDN, PEG3, PHLDA2, TSSC4, and UBE3A genes. Also disclosed is a method for improving pregnancy rate, wherein early embryos whose expression level of the MKRN3, NDN, PEG3, PHLDA2, TSSC4, or UBE3A gene is not increased, or the expression level of the CDKN1C, IGF2R, MAGEL2, or NAP1L5 gene is not decreased, are selected for planting into a suitable uterus for further development. Also disclosed are methods for increasing the likelihood of an early embryo to develop successfully into full-term pregnancy, wherein a suitable amount of siRNA corresponding to the PHLDA2 gene is injected into a fertilized egg which is in turn cultured further and planted into a suitable uterus.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: October 26, 2021
    Assignee: Wisconsin Alumni Research Foundation
    Inventor: Hasan Khatib
  • Patent number: 11154621
    Abstract: Compositions and method are therefore disclosed for treating chronic obstructive pulmonary disease (COPD) and/or pulmonary fibrosis (PF). In particular, disclosed a composition that contains one, two, or more cytidine diphosphate (CDP)-conjugated phospholipid precursors selected from the group consisting of CDP-choline, CDP-ethanolamine, and CDP-diacylglycerol in a pharmaceutically acceptable carrier for use in treating COPD and/or PF.
    Type: Grant
    Filed: June 27, 2018
    Date of Patent: October 26, 2021
    Assignee: Ohio State Innovation Foundation
    Inventor: Ian Christopher Davis
  • Patent number: 11158849
    Abstract: Provided are lithium ion batteries including a nano-crystalline graphene electrode. The lithium ion battery includes a cathode on a cathode current collector, an electrolyte layer on the cathode, an anode on the electrolyte layer, and an anode current collector on the anode. The anode and the cathode include a plurality of grains having a size in a range from about 5 nm to about 100 nm. The cathode has a double bonded structure in which a carbon of the graphene is combined with oxygen.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: October 26, 2021
    Assignees: Samsung Electronics Co., Ltd., Seoul National University R&DB Foundation
    Inventors: Minhyun Lee, Seongjun Park, Hyunjae Song, Hyeonjin Shin, Ki-Bum Kim, Yunhho Kang, Sanghun Lee
  • Patent number: 11158052
    Abstract: There is provided an ultrasound device comprising: ultrasound transducer(s), memory storing code, hardware processor(s) coupled to the ultrasound transducer(s) and the memory for executing stored code comprising: activating the transducer(s) for simultaneously transmitting at least one line with a predefined focus width, and receiving an indication of a plurality of narrow-focused received lines, inputting the indication of the narrow-focused received lines into a convolutional neural network (CNN) trained on pairs of ultrasound imaging data capturing rapid motion of the certain tissue of sample patient(s), including a single-line ultrasound imaging data captured based on a single line in response to a transmitted single narrow-focused pulse, and a multiple-line ultrasound imaging data captured based on receiving narrow-focused lines in response to simultaneously transmitted at least one line, outputting adjusted narrow-focused received lines, and computing an adjusted ultrasound image according to the adjust
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: October 26, 2021
    Assignee: Technion Research & Development Foundation Limited
    Inventors: Ortal Senouf, Sanketh Vedula, Alexander Bronstein, Michael Zibulevsky, Grigoriy Zurakhov, Oleg Michailovich
  • Patent number: 11155825
    Abstract: The present invention generally provides methods to generate plants with high frequency of spontaneous haploid genome doubling for use in doubled haploid production. The invention relates to the BUBR1 nucleic acid and protein sequences identified, which are associated with spontaneous haploid genome doubling.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: October 26, 2021
    Assignee: Iowa State University Research Foundation, Inc.
    Inventors: Thomas Lubberstedt, Ursula Karoline Frei
  • Publication number: 20210324032
    Abstract: Analogues of an alternatively spliced form of atrial natriuretic peptide (MANP) that exhibit pGC-A gain of function and can be used to treat cardiorenal and metabolic disease are described herein.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Applicant: Mayo Foundation for Medical Education and Research
    Inventor: John C. Burnett, Jr.
  • Publication number: 20210322571
    Abstract: Provided herein are nucleic acids, recombinant adeno-associated viral particles, compositions and methods related to treating Friedreich's ataxia. In some examples, the nucleic acids, recombinant adeno-associated viral particles, compositions and methods involve use of a FXN coding sequence, a truncated FXN 3? UTR, and a promoter.
    Type: Application
    Filed: July 1, 2021
    Publication date: October 21, 2021
    Applicant: University of Florida Research Foundation, Incorporated
    Inventors: Manuela Corti, PT, Barry John Byrne
  • Publication number: 20210323926
    Abstract: The present disclosure relates to novel lymphoid-specific tyrosine phosphatase (LYP, encoded by the PTPN22 gene) inhibitors, and to methods of making and using the novel LYP inhibitors. Thus, the compounds according to the disclosure may be used for treating diseases or disorders associated with PTPN22 genetic polymorphism, including type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosis, Graves' disease, Addison's disease, vitiligo, juvenile arthritis, Hashimoto thyroiditis, and other rarer diseases. Furthermore, these LYP inhibitors may be served for a novel class of cancer immunotherapy. The compounds can be injected or orally administered.
    Type: Application
    Filed: February 5, 2021
    Publication date: October 21, 2021
    Applicant: Purdue Research Foundation
    Inventors: Zhong-Yin Zhang, Jianping Lin
  • Publication number: 20210329780
    Abstract: A stretchable substrate according to an embodiment of the present invention comprises a first modulus region which has a first modulus, a second modulus region which is located in a plane direction with respect to the first modulus region and has a second modulus higher than the first modulus, and a third modulus region which is located between the first modulus region and the second modulus region and has an interface modulus which gradually changes between the first modulus and the second modulus, wherein the interface modulus of the third modulus region may be constant in the thickness direction thereof.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Applicant: Korea University Research and Business Foundation, Sejong Campus
    Inventors: Sang Il Kim, Mun Pyo Hong, Bo Sung Kim, Ho Won Yoon, Kyung Uk Ha, Yun O Im
  • Publication number: 20210328766
    Abstract: A method and apparatus for processing a ciphertext based on homomorphic encryption. The method includes determining an approximate polynomial corresponding to a modulus reduction for bootstrapping a ciphertext based on samples extracted from the modulus reduction, and bootstrapping the ciphertext based on the approximate polynomial.
    Type: Application
    Filed: February 10, 2021
    Publication date: October 21, 2021
    Applicants: SAMSUNG ELECTRONICS CO., LTD., SNU R&DB FOUNDATION, Industry Academic Cooperation Foundation Chosun University
    Inventors: Jong Seon NO, Yong Woo LEE, Young Sik KIM, Joon Woo LEE
  • Publication number: 20210325577
    Abstract: A plasmonic system is disclosed. The system includes at least one polarizer that is configured to provide at least one linearly polarized broadband light beam, an anisotropic plasmonic metasurface (APM) assembly having a plurality of nanoantennae each having a predetermined orientation with respect to a global axis representing encoded digital data, the APM assembly configured to receive the at least one linearly polarized broadband light beam and by applying localized surface plasmon resonance reflect light with selectable wavelengths associated with the predetermined orientations of the nanoantennae, and at least one analyzer that is configured to receive the reflected light with selectable wavelength, wherein the relative angles between each of the at least one analyzers and each of the at least one polarizers are selectable with respect to the global axis, thereby allowing decoding of the digital data.
    Type: Application
    Filed: April 7, 2021
    Publication date: October 21, 2021
    Applicant: Purdue Research Foundation
    Inventors: Alexander V. Kildishev, Di Wang, Zhaxylyk A. Kudyshev, Maowen Song, Alexandra Boltasseva, Vladimir M. Shalaev
  • Publication number: 20210322301
    Abstract: The present disclosure provides safe and effective dosing regimens of metal chelators as treatment for metal overload disorders and, in particular, iron overload and associated conditions.
    Type: Application
    Filed: December 17, 2020
    Publication date: October 21, 2021
    Applicants: Abfero Pharmaceuticals, Inc., University of Florida Research Foundation, Inc.
    Inventors: Steven Keith BURKE, Raymond J. BERGERON
  • Publication number: 20210322470
    Abstract: An ophthalmic composition or dosage form can include a therapeutically effective amount of a cross-linking agent and a pharmaceutically acceptable carrier. The composition or dosage form can be used to treat an ophthalmic condition by administering a therapeutically effective amount of the composition to an eye of a subject during a treatment period.
    Type: Application
    Filed: June 28, 2021
    Publication date: October 21, 2021
    Applicant: University of Utah Research Foundation
    Inventors: Balamurali K. Ambati, Hironori Uehara, Santosh Muddana
  • Publication number: 20210325827
    Abstract: A holographic display apparatus capable of providing an expanded viewing window and a display method are provided. The holographic display apparatus includes an image processor configured to provide computer generated hologram (CGH) data to a spatial light modulator, wherein the image processor is further configured to generate a hologram data array comprising information of the holographic image to be reproduced at the first resolution or a resolution less than the first resolution, perform an off-axis phase computation on the hologram data array at the second resolution, and then, generate the CHG data at the first resolution.
    Type: Application
    Filed: June 24, 2021
    Publication date: October 21, 2021
    Applicants: SAMSUNG ELECTRONICS CO., LTD., Korea University Research and Business Foundation, Sejong Campus
    Inventors: Hoon SONG, Hwi KIM, Jungkwuen AN, Hongseok LEE, Yunhee KIM, Chilsung CHOI
  • Publication number: 20210324129
    Abstract: The present disclosure provides to a novel flame retardant resin, wherein the resin is a reaction product of an epoxy material, a curing agent, and a partially esterified tannic acid of formula I, wherein TA represents a tannic acid moiety, R1 represents an optionally substituted C1-C6 straight or branched alkyl, an optionally substituted C3-C6 cyclic ring, an optionally substituted phenyl group, or any combination thereof, and n is 2-10.
    Type: Application
    Filed: February 15, 2021
    Publication date: October 21, 2021
    Applicant: Purdue Research Foundation
    Inventors: Jeffrey Paul Youngblood, Matthew Korey, John Alan Howarter, Natalie Burgos
  • Publication number: 20210327047
    Abstract: An example of an apparatus is provided. The apparatus includes a communication interface to receive an image of output from a printing device. The apparatus further includes a memory storage unit connected to the communication interface. The memory storage unit is to store the image of the output. The apparatus also includes a preprocessing engine to process the image. In addition, the apparatus includes a selective search engine to define a search area within the image. The selective search engine defines the search area of the image based on a local defect of unknown size. Furthermore, the apparatus includes a classification engine in communication with the selective search engine. The classification engine is to classify the search area for identification of the local defect.
    Type: Application
    Filed: January 11, 2019
    Publication date: October 21, 2021
    Applicants: Hewlett-Packard Development Company, L.P., Purdue Research Foundation
    Inventors: Jan Allebach, Richard Eric Maggard, Renee Jeanette Jessome, Mark Quentin Shaw, Qiulin Chen
  • Publication number: 20210329238
    Abstract: An image signal decoding method according to the present invention comprises the steps of: decoding information indicating whether a current block is encoded using a multi-mode intra prediction; when it is determined that the current block is encoded in the multi-mode intra prediction, dividing the current block into a plurality of partial blocks; and obtaining an intra prediction mode of each of the plurality of partial blocks.
    Type: Application
    Filed: June 30, 2021
    Publication date: October 21, 2021
    Applicant: Industry Academy Cooperation Foundation of Sejong University
    Inventors: Joo Hee MOON, Sung Won LIM, Dong Jae WON
  • Publication number: 20210323933
    Abstract: The present disclosure is concerned with piperazine-2,5-diones that are capable of inhibiting TGF-? and methods of treating cancers such as, for example, multiple myeloma and a hematologic malignancy, and methods of treating fibrotic conditions using these compounds. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
    Type: Application
    Filed: August 5, 2019
    Publication date: October 21, 2021
    Applicant: UAB Research Foundation
    Inventors: Mark J. Suto, Vandana V. Gupta, Wei Zhang, Joanne Murphy-Ullrich
  • Publication number: 20210327533
    Abstract: Provided herein are methods for generating a non-naturally occurring, broadly reactive, pan-epitopic antigen derived from a pathogen, such as a virus, bacterium, and the like, that is immunogenic and is capable of eliciting a broadly reactive immune response, such as a broadly reactive neutralizing antibody response, against the pathogen following introduction into a subject. Also provided is a non-naturally occurring immunogen generated using the methods, and vaccines and compositions comprising the immunogen. Methods of generating an immune response in a subject by administering the immunogen, vaccine, or composition are provided. In particular, the immunogen comprises the hemagglutinin (HA) or neuraminidase (NA) protein of influenza virus strains.
    Type: Application
    Filed: July 12, 2019
    Publication date: October 21, 2021
    Applicant: University of Georgia Research Foundation
    Inventors: James Daniel Allen, Ted Milburn Ross, Terianne Maiko Wong, Anne Gaelle Bebin Blackwell, Ivette Ariela Nunez, Zachary Beau Reneer, Ying Huang